IL13RA2 and breast cancer: Finally, based on this evidence, we hypothesized that if a metastasis suppressing IL-13-STAT6-TP63 signaling axis is activated in the absence of IL13Rα2 then STAT6 and TP63 expression levels may coordinately predict survival of patients with breast cancer.